Clinical utility of noninvasive fetal trisomy (NIFTY) test – early experience
Open Access
- 27 March 2012
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 25 (10) , 1856-1859
- https://doi.org/10.3109/14767058.2012.678442
Abstract
Objective: To report the initial experience of noninvasive prenatal diagnosis of fetal Down syndrome (The NIFTY test) in a clinical setting. Methods: The NIFTY test was offered as a screening test for fetal Down syndrome to pregnant women with a singleton pregnancy at 12 weeks of gestation or beyond. A satisfaction questionnaire was sent to the first 400 patients. Results: During a 6-month period, 567 NIFTY tests were performed. Over 90% of those studied were ethnic Chinese, and the mean age of the women studied was 36 years. The test was performed at 12–13 weeks of gestation in 49.21%. The median reporting time was 9 days. The test was positive for trisomy 21 in eight cases, and for trisomy 18 in 1 case; all were confirmed by fetal karyotyping. There was no false-positive result. Of the questionnaires, 182 completed responses were received. Over 95% had complete or almost complete resolution of anxiety. Except for one, all were satisfied with the NIFTY test, and all indicated that they would recommend the test to their friends. Conclusion: The NIFTY test was a highly specific test. Unnecessary invasive tests and associated fetal losses could be avoided in almost all women who have a normal fetus.Keywords
This publication has 12 references indexed in Scilit:
- Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencingThe Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011Prenatal Diagnosis, 2012
- Noninvasive prenatal diagnosis: pregnant women's interest and expected uptakePrenatal Diagnosis, 2011
- Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA SequencingPLOS ONE, 2011
- Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotypeUltrasound in Obstetrics & Gynecology, 2011
- Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical settingAmerican Journal of Obstetrics and Gynecology, 2011
- Screening for fetal aneuploidies at 11 to 13 weeksPrenatal Diagnosis, 2011
- First trimester combined screening for Trisomy 21 in Hong Kong: outcome of the first 10,000 casesThe Journal of Maternal-Fetal & Neonatal Medicine, 2009
- Pregnant Women's Responses to Information About an Increased Risk of Carrying a Baby with Down SyndromeBirth, 2006
- Presence of fetal DNA in maternal plasma and serumThe Lancet, 1997